Ratings
0
Nobody has rated this yet. Be the first!
Works
2
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates.
Site-specific trastuzumab maytansinoid antibody-drug conjugates with improved therapeutic activity through linker and antibody engineering
